PMID: 490531Aug 1, 1979Paper

Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent

Journal of Medicinal Chemistry
J HeeresJ Van Cutsem

Abstract

The preparation and antifungal properties of cis-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl-methyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine (I) are described. Ketoconazole has, at low oral doses, a high in vivi activity against vaginal candidosis in rats and against cutaneous candidosis in guinea pigs.

Citations

Oct 1, 1982·European Journal of Clinical Pharmacology·J J HeykantsJ M Merkus
Mar 1, 1983·European Journal of Obstetrics, Gynecology, and Reproductive Biology·H Van der PasJ Van Cutsem
Jul 1, 1986·European Journal of Obstetrics, Gynecology, and Reproductive Biology·W I van der MeijdenE Stolz
May 1, 1984·Molecular and Biochemical Parasitology·J D BermanD H Beach
Jun 14, 2005·Bioorganic & Medicinal Chemistry Letters·Lieven MeerpoelRay D Richards
Jan 25, 2003·Journal of Biochemical and Biophysical Methods·J L BernalM I Montequi
Feb 21, 2003·European Journal of Medicinal Chemistry·Young-Min NaPatrice Le Pape
Nov 19, 2002·Clinics in Dermatology·Virendra N Sehgal, Sujay Khandpur
Jan 11, 2013·Preparative Biochemistry & Biotechnology·Yuliang Zhang, Zhongqiang Zhou
Jan 1, 1993·International Journal of Dermatology·M J StillerJ L Shupack
Jun 1, 1980·Antimicrobial Agents and Chemotherapy·H Van den BosscheJ M van Cutsem
Jan 1, 1981·Antimicrobial Agents and Chemotherapy·F A AndrewsG A Sarosi
Feb 1, 1982·Antimicrobial Agents and Chemotherapy·W H Beggs, G A Sarosi
Jan 1, 1983·Antimicrobial Agents and Chemotherapy·H MinagawaN Nakamizo
Aug 1, 1986·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·M Schaude, J G Meingassner
Jan 1, 1990·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·M SchaudeH Mieth
May 15, 1979·Experientia·D ThienpontP A Janssen
Sep 1, 1982·Infection·B A DijkmansJ W van der Meer
Oct 17, 2014·Journal of Chemical Biology·Josie E ParkerSteven L Kelly
Nov 21, 2014·Expert Opinion on Drug Safety·Aditya K GuptaKelly A Foley
Aug 29, 2003·Journal of Enzyme Inhibition and Medicinal Chemistry·Marc Le BorgnePaul J Nicholls
Apr 14, 2007·Dermatologic Clinics·Alexandra Y ZhangBoni E Elewski
Mar 1, 1982·Clinical and Experimental Dermatology·R J Hay, Y M Clayton
Feb 27, 2003·Journal of Veterinary Pharmacology and Therapeutics·H Vanden BosscheF Rochette
Jun 15, 2007·Expert Opinion on Pharmacotherapy·Jan FaergemannH Degreef
Feb 1, 2015·European Journal of Endocrinology·Eleni Daniel, John D C Newell-Price
Jul 5, 2016·Expert Opinion on Therapeutic Patents·Juan B RodriguezSergio H Szajnman
Dec 22, 2011·International Journal of Microbiology·Patrick VandeputteAlix T Coste
Oct 30, 2016·Bioorganic & Medicinal Chemistry Letters·Benjamin E BlassMahesh Yanamandra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.